TILDRAKIZUMAB-ASMN vs TIMOLOL: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
TILDRAKIZUMAB-ASMN vs TIMOLOL: Safety Overview
| Metric | TILDRAKIZUMAB-ASMN | TIMOLOL |
|---|---|---|
| Total FAERS Reports | 1,621 | 7,450 |
| Deaths Reported | 92 | 66 |
| Death Rate | 5.7% | 0.9% |
| Hospitalizations | 69 | 450 |
| Average Patient Age | 63.8 yrs | 67.1 yrs |
| % Female Patients | 53.8% | 61.9% |
| FDA Approval Date | N/A | Approved Prior to Jan 1, 1982 |
| Manufacturer | N/A | Bausch & Lomb Incorporated |
| Route | N/A | OPHTHALMIC |
| Marketing Status | Prescription | Discontinued |